XIFIN Launches RPM 12 to Accelerate Workflow and Improve Financial Performance for Diagnostic Providers Amid COVID-19
Expanded Capabilities, Including Advanced Analytics, Client & Patient Portals, and Insurance Discovery Enable More Efficient Management of Revenue Cycles and Collections SAN DIEGO, Calif., - September 30, 2020 – Diagnostic providers across the U.S. are overwhelmed by a high number of testing volumes – on average, 165% of their normal levels – as the country continues to...
XIFIN Executives Expect 15% Increase in Fall COVID-19 Testing Volumes; Seeing Regional Labs Pick Up Overflow from Larger, National Players
Company highlights key factors expected to impact Q4 COVID-19 testing during UBS analyst event SAN DIEGO, Calif., - September 22, 2020 – COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as students go back to school and flu season hits its peak. XIFIN...
XIFIN LIS 7 Helps Laboratories Process Increased Testing Volumes Due to COVID-19 Crisis
New Capabilities, Including Dolbey Fusion Narrate, Drive Increased Productivity and Patient Throughput Amid Surge SAN DIEGO, Calif., — September 11, 2020 — The COVID-19 pandemic has created an overwhelming demand for testing, with laboratories nationwide seeing, on average, testing volumes at 1.6 times their normal levels. This pressure demonstrates the need for technology that not only...
Notal Vision Diagnostic Clinic Implements XIFIN RPM to Improve Claim Accuracy, Timely Reimbursement and Patient Experience
The first ophthalmic home diagnostic services company upgrades revenue cycle management platform to provide a better patient experience and prepare for business growthSAN DIEGO, Calif., — August 19, 2020 — Today, XIFIN has announced a collaboration with Notal Vision Diagnostic Clinic, a leading healthcare provider of ophthalmic remote patient monitoring services, to improve claim...
XIFIN Data Reveals COVID-19 Antibody Testing Volumes Surprisingly Low; Better Payor Coverage Needed to Support Testing Increase
As America returns to work, XIFIN shares update on nationwide COVID-19 testing volume and payor behavior during UBS expert event SAN DIEGO, Calif., — June 29, 2020 — Diagnostic laboratories continue to be a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic. XIFIN CEO Lâle White and Kyle Fetter, Executive Vice...
Utah Cancer Specialists Implements XIFIN VisualStrata to Provide Care Teams with Improved Data Insights
Award-winning precision medicine informatics platform integrates data from disparate systems to provide clinicians with greater patient insights and supports value-based care initiativesSAN DIEGO, Calif., — March 25, 2020 — Precision medicine is especially promising in oncology care, but the massive amounts of data that exists – often in silos – makes it challenging for clinicians to...
New XIFIN Data Reveals Routine Lab Volume Down Approximately 60% but Coronavirus Testing Adds Back Nearly 20%
Company introduces new weekly XIFIN Lab Volume Index; executives shared insights with UBS analysts during teleconference on lab testing activity and dynamics SAN DIEGO, Calif., — April 22, 2020 — Diagnostic laboratories are at the forefront of US efforts to assess the spread of COVID-19. Elective and non-urgent testing have been delayed as coronavirus testing has rolled out over the...
XIFIN Announces COVID-19 Advocacy Efforts to Support Diagnostic Labs in Response to Pandemic
Company joins COVID-19 Healthcare Coalition and creates independent resource center to provide laboratories with easy access to new payor data SAN DIEGO, Calif., — April 7, 2020 — The nature of public health outbreaks demands that health systems respond rapidly. Laboratory medicine experts have historically fulfilled this need by developing tests to accurately identify pathogens far...
- 1 of 17
- next ›